Diagnos Inc.



StageZero Life Sciences Ltd.
Latest Comments
image_pdfimage_print

Andre Larente speaks to Mario Drolet about the importance of the DIAGNOS agreement with IRIS

In a recent InvestorIntel interview, Mario Drolet speaks with André Larente, President of Diagnos Inc. (TSXV: ADK | OTCQB: DGNOF) […]


Agreement with IRIS a ‘major breakthrough’ for DIAGNOS path to global commercialization

Did you know that doctors can study the retina of your eye and get an early reading on the condition […]


Diagnos’ André Larente on Entering the DACH and Central European Healthcare Market

In a recent InvestorIntel interview, Tracy Weslosky spoke with André Larente President of Diagnos Inc. (TSXV: ADK | OTCQB: DGNOF) […]


Expanding globally in the AI image based diagnosis sector, Diagnos is actively commercializing their CARA technology

CARA’s Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is accessible securely […]


Thompson on DIAGNOS and the ‘exploding’ AI healthtech industry

AI Healthcare Provider Diagnos Continues to Sign Deals and Partnerships Amid COVID-19 Crisis Diagnos Inc. (TSXV: ADK | OTCQB: DGNOF […]


Diagnos’ Andre Larente on the benefits of using AI for the early detection of critical health issues

“Our (AI) technology works, its in production (CARA). We are fully funded….the markets we are going after are extremely big…” […]


Diagnos’ AI Platform to Fight Vision Loss Continues to Expand Globally

Diagnos Inc. (TSXV: ADK | OTCQB: DGNOF) is a software platform provider for the early detection of critical health issues […]